Findings showed 12.1% of atogepant-treated patients discontinued treatment due to adverse events compared with 29.6% of topiramate-treated patients. Topline results were announced from a phase 3 trial ...

NEW YORK (Reuters Health) - Topiramate is safe and effective in preventing migraine in 12- to 17-year-old patients, according to a report in the journal Pediatrics. While topiramate is FDA-approved ...

(Reuters) -AbbVie said on Wednesday its migraine drug met the main goal and was superior to a widely used generic treatment in a head-to head late-stage trial. The U.S. drugmaker has been expanding ...

The Consumer Justice Foundation, a free online resource designed to provide consumers with information regarding how they should deal with large corporations that include pharmaceutical drug companies ...

TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of ...

NEW YORK (Reuters Health) - Preventive treatment with topiramate (Topamax) is associated with a reduction in lost productivity due to migraines, researchers report. Using data from two trials, Dr.

Topiramate, a drug for migraine prophylaxis, may have beneficial effects on the kidneys. Migraine treatment with topiramate is linked to lower risks of end-stage kidney disease (ESKD), death, and ...

Topiramate (Topamax) is an anti-seizure medication. However, doctors sometimes prescribe it off-label to help people lose weight.

How Does Topirmate for Weight Loss Work? Topiramate, also sold under the brand name Topamax, is a drug approved by the U.S. Food and Drug Administration (FDA) for epilepsy and migraines. It’s also ...

The study met the primary endpoint of treatment discontinuation due to adverse events (AEs), demonstrating that atogepant, a calcitonin gene-related peptide (CGRP) receptor antagonist, had fewer ...